检索结果 - Fraser Cummings
- Showing 1 - 20 results of 36
- Go to Next Page
-
1
JAK1 inhibition and inflammatory bowel disease 由 Clare Harris, Fraser Cummings
出版 2020Revisão -
2
Medical management of Crohn’s disease 由 Fraser Cummings, Satish Keshav, Simon Travis
出版 2008Revisão -
3
-
4
-
5
-
6
-
7
-
8
MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1 由 Markus Gwiggner, Rocío T. Martínez-Nuñez, Simon Whiteoak, Victor P. Bondanese, A Claridge, Jane Collins, Fraser Cummings, Tilman Sanchez‐Elsner
出版 2018Artigo -
9
-
10
-
11
Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS] 由 Esther Ventress, David Young, Sohail Rahmany, Clare Harris, Marion Bettey, Trevor Smith, Helen Moyses, Magdalena Lech, Markus Gwiggner, Richard Felwick, Fraser Cummings
出版 2021Artigo -
12
-
13
Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients 由 Kevin Whelan, Trevor Murrells, Myfanwy Morgan, Fraser Cummings, Catherine Stansfield, Anne Todd, Shaji Sebastian, Alan Lobo, Miranda Lomer, James O. Lindsay, Wladyslawa Czuber‐Dochan
出版 2020Artigo -
14
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial 由 Geert D’Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M. Irving, Byong Duk Ye, Dong‐Hyeon Kim, Sang-Wook Yoon, Shomron Ben–Horin
出版 2023Artigo -
15
Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme 由 Violeta Razanskaite, Marion Bettey, Louise Downey, Julia L. Wright, J Callaghan, Miles Rush, Simon Whiteoak, Sarah Ker, Kim Perry, Caron Underhill, Efrem Eren, Iftikar Ahmed, Fraser Cummings
出版 2017Artigo -
16
P245 Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologics 由 Giulia Bartalucci, Frederick R. Taylor, C. Gleave, Liz Dobson, Keith Bodger, Susanna Dodd, Stuart Bloom, Alun Passey, R Nissinen, Daniel Wirth, Darian Andreas, J Lee, Fraser Cummings
出版 2024Artigo -
17
-
18
Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach 由 Silvio Danese, Rupa Banerjee, Fraser Cummings, Iris Dotan, Paulo Gustavo Kotze, Rupert W. Leong, Kristine Paridaens, Laurent Peyrin‐Biroulet, Glyn Scott, Gert Van Assche, Jan Wehkamp, Jesús K. Yamamoto‐Furusho
出版 2018Artigo -
19
IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease 由 Mark Tremelling, Fraser Cummings, Sheila Fisher, John Mansfield, Rhian Gwilliam, Andrew Keniry, Elaine R. Nimmo, Hazel E. Drummond, Clive M. Onnie, Natalie J. Prescott, Jeremy Sanderson, Francesca Bredin, Carlo Berzuini, Alastair Forbes, Cathryn M. Lewis, Lon R. Cardon, Panos Deloukas, Derek P. Jewell, Christopher G. Mathew, Miles Parkes, Jack Satsangi
出版 2007Artigo -
20
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres 由 David Young, Sohail Rahmany, Deborah R. Taylor, E. A. Davis, Michael Colwill, Sonia Kalyanji Mehta, Roisin Campbell, Karl Hazel, Karishma Sethi-Arora, Susan Ritchie, Ashley Heinson, Helen Moyses, Keith Bodger, Emma Johnston, Lucy Hicks, Anjan Dhar, Jimmy K. Limdi, Rachel Cooney, John Paul Seenan, Kamal Patel, Alissa Walsh, Fraser Cummings
出版 2025Artigo
相关主题
Medicine
Internal medicine
Disease
Inflammatory bowel disease
Ulcerative colitis
Crohn's disease
Biology
Gene
Immunology
Infliximab
Gastroenterology
Genetics
Genome-wide association study
Genotype
Single-nucleotide polymorphism
Cohort
Genetic association
Adverse effect
Clinical trial
Odds ratio
Pathology
Thiopurine methyltransferase
Tumor necrosis factor alpha
Adalimumab
Azathioprine
Discontinuation
Haplotype
Immune system
Intensive care medicine
Randomized controlled trial